De Pesticideyndustry Finansieret it Measte Ûndersyk nei Pesticiden
June 23, 2026 · Frisian News
Pesticide makers finance roughly 75 percent of research concluding their products are safe. Studies show industry-funded research reaches different conclusions than independent work.
FryskSawat 75 prosint fan it ûndersyk dat konkludearret dat pesticiden feilich binne, wurdt finansierd troch de pesticideyndustry sels. Dit feit allinnich seit al in soad oer hoe't regeljouwers en it publyk bepale oft gemyske stoffen gefaarlik binne. In struktureel belangekonflikt sit yn it hert fan it goedkarringsproses.
It patroan is finansjeel logysk. As in pesticidebedriuw ûndersyk nei syn eigen produkt betellet, streamt it jild mar ien kant op. Jo stúdzje ûntdekket dat de gemyske stof kanker by rotten feroarsaket en it bedriuw ferliest miljarden yn ferkeapen en rjochtsaken. Jo stúdzje ûntdekket dat it feilich is en de oandielen fan it bedriuw stije. Regeljouwers sjogge it publisearre artikel en geane derfan út dat ûnôfhinklike wittenskip it fuortbrocht hat.
De sifers bewize dat de fertekening wurket. Ûndersiken finansierd troch de yndustry konkludearje dat in pesticide ûnskeadlik is fjouwer kear faker as ûnôfhinklik ûndersyk nei deselde gemyske stof. Dit ferskil kin net ferklearre wurde troch bettere apparatuer of tûkere wittenskippers oan de kant fan de yndustry. It wjerspegelet yn stee dêrfan in finansieringsstelsel wêryn it ferkearde antwurd de jildjouer jild kostet. It goede antwurd makket harren ryk.
Bayer, Corteva en Syngenta bestelle ûndersiken fia universiteiten en ûndersyksbedriuwen, en sitearje dêrnei de resultaten yn regeljouwingshearings. Net folle regeljouwers stelle fragen. De measte akseptearje de publisearre befiningen as neutrale wittenskip. It prikkelstelsel soarget foar stilte. Betwist yndustrifinansiering en jo ferlieze ûndersyksjild fan deselde boarnen dy't no it measte akademyske ûndersyk oer it ûnderwerp kontrolearje.
Regeljouwers sizze dat sy al it bewiis gelyk wege. Dat dogge sy net. Sy akseptearje artikelen dy't ta konklúzjes liede dy't de finansjele belangen tsjinje fan dyjingen dy't derfar betelle hawwe. Neam it wat it is: marketing mei in referinsjelist.
About 75 percent of research concluding that pesticides are safe comes from studies funded by the pesticide industry itself. This fact alone tells you something important about how regulators and the public evaluate whether chemicals are dangerous. A structural conflict of interest sits at the center of the approval process.
The pattern makes financial sense. When a pesticide company pays for research on its own product, the money flows only one direction. Your study finds the chemical causes cancer in rats and the company loses billions in sales and lawsuits. Your study finds it safe and company stock rises. Regulators see the published paper and assume independent science produced it.
The numbers prove the bias works. Industry-funded studies conclude a pesticide is harmless four times more often than independent research examining the same chemical. This gap cannot be explained by better equipment or smarter scientists on the industry side. It reflects instead a funding system where the wrong answer costs the financier money. The right answer makes them rich.
Bayer, Corteva, and Syngenta commission studies through universities and research firms, then cite the results in regulatory hearings. Few regulators push back. Most accept the published findings as neutral science. The incentive structure ensures silence. Challenge industry funding and you lose grant money from the same sources that now control most of academic research on the topic.
Regulators claim to weigh all evidence equally. They do not. They accept papers that reach conclusions serving the financial interests of whoever paid for them. Call it what it is: marketing with a references section.
Published June 23, 2026 · Frisian News · Ljouwert, Fryslân